ADXS — Ayala Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $24.30m
- $27.23m
- $0.01m
U.S. STOCKS ON THE MOVE-Merck, Kellogg, Apache, Tesla, Boeing
U.S. STOCKS ON THE MOVE-Boeing, Pier 1 Imports, Tesla, Cellect, Kellogg
U.S. STOCKS ON THE MOVE-Cellect, Zynga, Goldman Sachs, Kellogg, Merck
U.S. STOCKS ON THE MOVE-Cellect, Advaxis, Kellogg, Pier 1 Imports
Advaxis jumps as FDA green-lights prostate cancer trial
Brief: Advaxis Announces FDA Clearance Of Ind For Adxs-504 For Treatment Of Prostate Cancer
Brief: Advaxis Inc Announces Submission Of IND Application For ADXS-HOT Drug Candidate For Prostate Cancer
Brief: Advaxis And UCLA Enter Collaboration For Glioblastoma Immunotherapy Discovery Research
U.S. STOCKS ON THE MOVE-PG&E, Bed Bath & Beyond, RA Pharma, ProPetro Holding
U.S. STOCKS ON THE MOVE-FuelCell Energy, International Seaways, Harley-Davidson
U.S. STOCKS ON THE MOVE-Uber, Akcea Therapeutics, E*Trade Financial, Match Group
Advaxis shares jump on improved survival data from prostate cancer drug
Brief: Advaxis Updates Prolonged Survival Data In Phase 1/2 ADXS-PSA Trial
U.S. STOCKS ON THE MOVE-Synnex, Lannett, Celgene Corp, Titan Medical
Brief: Advaxis Inc - Received Written Notice From Staff Of Listing Qualifications Department Of Nasdaq Stock Market
Brief: Advaxis Reports Qtrly Loss Per Share $1
Brief: Altium Capital Management Lp Reports 9.87% Passive Stake In Advaxis Inc
U.S. STOCKS ON THE MOVE-Chiasma, Hasbro, LSC Communications
Advaxis continues plunge on $16 mln capital raise